586-29309-67434 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-12
Dose 1 — Pfizer-BioNTech
2021-09-02
Dose 2 — Pfizer-BioNTech
2021-09-09
Registered in v-safe
2021-09-09
Survey response — day 7, dose 2
MedDRA: Erythema, Facial pain, Genital pain, Genital rash, Musculoskeletal pain, Pain, Pain in extremity, Pruritus, Pruritus genital, Rash, Urticaria — Feeling: Poor · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Rash/hives, redness, swelling, itching, pain - face, chin, upper extremities, trunk, groin/genitalia (external), intergluteal cleft, inner thighs

MedDRA releases: 2024-11 · check-in free text available
2021-09-09
Report sent to call center — day 7, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-09-15
Call 1 — Left Voicemail
2021-09-16
Survey response — day 14, dose 2
MedDRA: Medical counselling, Pruritus, Rash — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: On Friday, 9/10, my palms developed a rash and began itching. I called my dermatologist to let her know I wasnt getting any relief from the Methylprednisolone Dospak (despite almost being finished the pack). She prescribed me Prednisone.

MedDRA releases: 2024-11 · check-in free text available
2021-09-16
Report sent to call center — day 14, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-09-17
Call 1 — Left Voicemail
2021-09-17
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-09-23
Survey response — day 21, dose 2
MedDRA: Headache, Paranasal sinus discomfort — Feeling: Poor

Free text: Headache and sinus pressure

MedDRA releases: 2024-11 · check-in free text available
2021-09-30
Survey response — day 28, dose 2
MedDRA: Rash, Urticaria — Feeling: Poor

Free text: Hives/rash developed on arms, underarms, inner thighs and groin area. This occurred after finishing Prednisone.

MedDRA releases: 2024-11 · check-in free text available
2021-10-12
Survey response — day 35, dose 2
MedDRA: Rash, Rash pruritic — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Itchy rashes on face, neck, arms, underarms, palms, inner thighs, groin and glutes

MedDRA releases: 2024-11 · check-in free text available
2021-10-12
Report sent to call center — day 35, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-14
Survey response — day 42, dose 2
MedDRA: Pruritus, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Severe itching and rashes

MedDRA releases: 2024-11 · check-in free text available
2021-10-14
Report sent to call center — day 42, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-10-18
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-12	Pfizer-BioNTech	No
2	2021-09-02	Pfizer-BioNTech	No

Call center

4 call center cases

4 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 9 — day 7, dose 2

2021-09-09

Systemic reaction (other): Rash/hives, redness, swelling, itching, pain - face, chin, upper extremities, trunk, groin/genitalia (external), intergluteal cleft, inner thighs

Release 9 — day 14, dose 2

2021-09-16

Symptoms: On Friday, 9/10, my palms developed a rash and began itching. I called my dermatologist to let her know I wasnt getting any relief from the Methylprednisolone Dospak (despite almost being finished the pack). She prescribed me Prednisone.

Release 9 — day 21, dose 2

2021-09-23

Symptoms: Headache and sinus pressure

Release 9 — day 28, dose 2

2021-09-30

Symptoms: Hives/rash developed on arms, underarms, inner thighs and groin area. This occurred after finishing Prednisone.

Release 10 — day 35, dose 2

2021-10-12

Symptoms: Itchy rashes on face, neck, arms, underarms, palms, inner thighs, groin and glutes

Release 10 — day 42, dose 2

2021-10-14

Symptoms: Severe itching and rashes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	·	·	✓
SD	Medical counselling	·	·	✓
SD	Paranasal sinus discomfort	·	·	✓
SD	Pruritus	·	·	✓
SD	Rash	·	·	✓
SD	Rash pruritic	·	·	✓
SD	Urticaria	·	·	✓
SRO	Erythema	·	·	✓
SRO	Facial pain	·	·	✓
SRO	Genital pain	·	·	✓
SRO	Genital rash	·	·	✓
SRO	Musculoskeletal pain	·	·	✓
SRO	Pain	·	·	✓
SRO	Pain in extremity	·	·	✓
SRO	Pruritus	·	·	✓
SRO	Pruritus genital	·	·	✓
SRO	Rash	·	·	✓
SRO	Urticaria	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release